Eli Lilly and Co Newsroom

Eli Lilly Price Target Raised to $1000.00/Share From $875.00 by Wells Fargo

Dow JonesAug 9 12:05 ET

Redburn Atlantic Adjusts Eli Lilly Price Target to $640 From $600

MT NewswiresAug 9 10:54 ET

Jefferies Remains a Buy on Eli Lilly & Co (LLY)

TipRanksAug 9 09:36 ET

Eli Lilly Analyst Ratings

BenzingaAug 9 06:48 ET

Eli Lilly & Co (LLY) Buy Rating Affirmed on Strong HFpEF Data and Competitive Edge Over Novo Nordisk (NVO)

TipRanksAug 9 06:00 ET

Eli Lilly Analyst Ratings

BenzingaAug 5 13:53 ET

Truist Financial Maintains Eli Lilly and Co(LLY.US) With Buy Rating

Moomoo NewsAug 5 07:34 ET

Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025

Moomoo NewsAug 5 04:31 ET

Truist Financial Maintains Eli Lilly and Co(LLY.US) With Buy Rating

Moomoo NewsAug 2 08:34 ET

Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,041

Moomoo NewsAug 2 08:31 ET

Eli Lilly & Co Faces European Market Challenges; Analyst Maintains Hold Rating

TipRanksJul 30 05:18 ET

Barclays Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,025

Moomoo NewsJul 29 04:31 ET

Eli Lilly & Co (LLY) Gets a Buy From Barclays

TipRanksJul 29 04:21 ET

Cantor Fitzgerald Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $885

Moomoo NewsJul 25 08:31 ET

Eli Lilly and Co Analyst Ratings

BenzingaJul 24 15:47 ET

Wolfe Research Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,117

Moomoo NewsJul 24 15:31 ET

Wolfe Research Adjusts Eli Lilly's Price Target to $1,117 From $909

MT NewswiresJul 24 12:23 ET

Eli Lilly, Novo Are Weight-Loss Winners. Rivals Won't Be an Issue for Years: Analyst. -- Barrons.com

Barron'sJul 22 08:58 ET

HSBC Raises Price Target on Eli Lilly to $1,100 From $880, Maintains Buy Rating

MT NewswiresJul 19 08:25 ET

TD Cowen Raises Price Target on Eli Lilly to $1,050 From $850

MT NewswiresJul 17 09:33 ET